|
|
|
Insider
Information: |
Crowley John F |
Relationship: |
Director |
City: |
Cranbury |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
590,194 |
|
Indirect Shares
|
97,759 |
|
|
Direct
Value |
$6,353,484 |
|
|
Indirect Value
|
$688,536 |
|
|
Total
Shares |
687,953 |
|
|
Total
Value |
$7,042,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
41,667 |
128,359 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
203,252 |
331,611 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-06-15 |
4 |
D |
$8.79 |
$43,994 |
D/D |
(5,005) |
326,606 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-09-26 |
4 |
B |
$14.36 |
$20,032 |
D/D |
1,395 |
328,001 |
2.81 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-12 |
4 |
OE |
$14.25 |
$5,414,810 |
D/D |
380,000 |
708,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-12 |
4 |
AS |
$14.25 |
$5,414,810 |
D/D |
(380,000) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-13 |
4 |
OE |
$14.75 |
$326,867 |
D/D |
22,160 |
350,161 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-13 |
4 |
AS |
$14.75 |
$326,867 |
D/D |
(22,160) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-16 |
4 |
AS |
$14.75 |
$695,241 |
D/D |
(47,135) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-16 |
4 |
OE |
$14.75 |
$695,241 |
D/D |
47,135 |
375,136 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-17 |
4 |
OE |
$14.75 |
$777,650 |
D/D |
52,722 |
380,723 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-17 |
4 |
AS |
$14.75 |
$777,650 |
D/D |
(52,722) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-18 |
4 |
OE |
$14.76 |
$280,544 |
D/D |
19,013 |
347,014 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-10-18 |
4 |
AS |
$14.76 |
$280,544 |
D/D |
(19,013) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-04 |
4 |
AS |
$13.61 |
$642,734 |
D/D |
(47,213) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-04 |
4 |
OE |
$13.61 |
$642,734 |
D/D |
47,213 |
375,214 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-11 |
4 |
OE |
$13.52 |
$164,973 |
D/D |
12,206 |
340,207 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-11 |
4 |
AS |
$13.52 |
$164,973 |
D/D |
(12,206) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-20 |
4 |
AS |
$13.51 |
$878,929 |
D/D |
(65,075) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-20 |
4 |
OE |
$13.51 |
$878,929 |
D/D |
65,075 |
393,076 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-21 |
4 |
OE |
$13.51 |
$6,836 |
D/D |
506 |
358,507 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-21 |
4 |
AS |
$13.51 |
$6,836 |
D/D |
(506) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-28 |
4 |
OE |
$14.75 |
$192,497 |
D/D |
13,050 |
341,051 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-28 |
4 |
AS |
$14.75 |
$192,497 |
D/D |
(13,050) |
328,001 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
|
2017-12-29 |
4 |
AS |
$14.75 |
$87,320 |
D/D |
(5,920) |
328,001 |
0 |
- |
|
298 Records found
|
|
Page 4 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|